(Total Views: 533)
Posted On: 12/23/2022 12:41:21 PM
Post# of 153941
Pourhassan allegedly knew that, in truth and in fact, leronlimab’s clinical studies failed to achieve the results necessary to obtain any form of FDA approval for use as a treatment for COVID-19 and the results CytoDyn publicly touted were neither statistically significant nor scientifically sound.”
It's the above statement that worries me about how the FDA view's CYDY
It's the above statement that worries me about how the FDA view's CYDY
(2)
(0)
